200–400 mcg — reported, not studied
200–400 mcg two or three times a week after training, by injection under the skin or into muscle. The same review prints the same quantity again as a daily amount, calls the protocols it collects internally inconsistent, and notes that the only work ever done on this peptide put a fragment carrying no polyethylene glycol onto cultured cells and into mice.
| Water added | Concentration | Draw, low to high |
|---|---|---|
| 1 mL | 2.00 mg/mL | 10.0 to 20.0 units |
| 2 mL | 1.00 mg/mL | 20.0 to 40.0 units |
| 3 mL | 0.67 mg/mL | 30.0 to 60.0 units |
indirect evidenceDominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol 2026 — tabulates self-reported online dosing patterns beside the clinical doses, stating the reported values must not be read as clinically validated, regulatory-approved or safe · retrieved 2026-08-12
